South Korea
· Delayed Price · Currency is KRW Daewon Pharmaceutical Statistics
Total Valuation
KRX:003220 has a market cap or net worth of KRW 283.78 billion. The enterprise value is 417.26 billion.
| Market Cap | 283.78B |
| Enterprise Value | 417.26B |
Important Dates
The next estimated earnings date is Wednesday, August 13, 2025.
| Earnings Date | Aug 13, 2025 |
| Ex-Dividend Date | Dec 27, 2024 |
Share Statistics
KRX:003220 has 21.43 million shares outstanding. The number of shares has decreased by -0.06% in one year.
| Current Share Class | 21.43M |
| Shares Outstanding | 21.43M |
| Shares Change (YoY) | -0.06% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 38.80% |
| Owned by Institutions (%) | 12.57% |
| Float | 12.84M |
Valuation Ratios
The trailing PE ratio is 24.66 and the forward PE ratio is 23.04. KRX:003220's PEG ratio is 0.33.
| PE Ratio | 24.66 |
| Forward PE | 23.04 |
| PS Ratio | 0.47 |
| PB Ratio | 1.00 |
| P/TBV Ratio | 1.30 |
| P/FCF Ratio | 42.82 |
| P/OCF Ratio | 6.43 |
| PEG Ratio | 0.33 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 9.76, with an EV/FCF ratio of 62.96.
| EV / Earnings | 40.19 |
| EV / Sales | 0.70 |
| EV / EBITDA | 9.76 |
| EV / EBIT | 18.99 |
| EV / FCF | 62.96 |
Financial Position
The company has a current ratio of 1.13, with a Debt / Equity ratio of 0.65.
| Current Ratio | 1.13 |
| Quick Ratio | 0.59 |
| Debt / Equity | 0.65 |
| Debt / EBITDA | 4.43 |
| Debt / FCF | 27.74 |
| Interest Coverage | 2.40 |
Financial Efficiency
Return on equity (ROE) is 2.13% and return on invested capital (ROIC) is 2.84%.
| Return on Equity (ROE) | 2.13% |
| Return on Assets (ROA) | 2.23% |
| Return on Invested Capital (ROIC) | 2.84% |
| Return on Capital Employed (ROCE) | 5.46% |
| Revenue Per Employee | 465.86M |
| Profits Per Employee | 8.09M |
| Employee Count | 1,283 |
| Asset Turnover | 1.03 |
| Inventory Turnover | 2.73 |
Taxes
In the past 12 months, KRX:003220 has paid 4.59 billion in taxes.
| Income Tax | 4.59B |
| Effective Tax Rate | 43.21% |
Stock Price Statistics
The stock price has decreased by -6.65% in the last 52 weeks. The beta is 0.42, so KRX:003220's price volatility has been lower than the market average.
| Beta (5Y) | 0.42 |
| 52-Week Price Change | -6.65% |
| 50-Day Moving Average | 13,618.00 |
| 200-Day Moving Average | 14,180.45 |
| Relative Strength Index (RSI) | 35.66 |
| Average Volume (20 Days) | 53,708 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, KRX:003220 had revenue of KRW 597.69 billion and earned 10.38 billion in profits. Earnings per share was 486.44.
| Revenue | 597.69B |
| Gross Profit | 279.70B |
| Operating Income | 20.72B |
| Pretax Income | 10.62B |
| Net Income | 10.38B |
| EBITDA | 41.51B |
| EBIT | 20.72B |
| Earnings Per Share (EPS) | 486.44 |
Balance Sheet
The company has 59.12 billion in cash and 183.86 billion in debt, giving a net cash position of -124.73 billion or -5,819.64 per share.
| Cash & Cash Equivalents | 59.12B |
| Total Debt | 183.86B |
| Net Cash | -124.73B |
| Net Cash Per Share | -5,819.64 |
| Equity (Book Value) | 282.83B |
| Book Value Per Share | 12,787.57 |
| Working Capital | 29.38B |
Cash Flow
In the last 12 months, operating cash flow was 44.14 billion and capital expenditures -37.51 billion, giving a free cash flow of 6.63 billion.
| Operating Cash Flow | 44.14B |
| Capital Expenditures | -37.51B |
| Free Cash Flow | 6.63B |
| FCF Per Share | 309.20 |
Margins
Gross margin is 46.80%, with operating and profit margins of 3.47% and 1.74%.
| Gross Margin | 46.80% |
| Operating Margin | 3.47% |
| Pretax Margin | 1.78% |
| Profit Margin | 1.74% |
| EBITDA Margin | 6.95% |
| EBIT Margin | 3.47% |
| FCF Margin | 1.11% |
Dividends & Yields
This stock pays an annual dividend of 300.00, which amounts to a dividend yield of 2.27%.
| Dividend Per Share | 300.00 |
| Dividend Yield | 2.27% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 61.24% |
| Buyback Yield | 0.06% |
| Shareholder Yield | 2.30% |
| Earnings Yield | 3.66% |
| FCF Yield | 2.34% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on March 7, 2022. It was a forward split with a ratio of 1.03.
| Last Split Date | Mar 7, 2022 |
| Split Type | Forward |
| Split Ratio | 1.03 |
Scores
KRX:003220 has an Altman Z-Score of 2.38 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.38 |
| Piotroski F-Score | 4 |